Healthcare leaders react to Biden’s withdrawal from the 2024 election; Agilent to buy Biovectra for $925 million; WuXi AppTec increases congressional lobbying effort.
Rx Rundown: Roche, Vertex Pharmaceuticals, CordenPharma and more
J&J also lowered its full-year adjusted operational EPS guidance as a result of costs associated with recent strategic acquisitions that ‘more than offset the improvement.’
Report: Pharma hikes prices of 195 drugs, many higher than rate of inflation